Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists Δ9-THC, WIN 55,212-2 and anandamide in mice
- 18 March 1999
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 263 (1) , 29-32
- https://doi.org/10.1016/s0304-3940(99)00096-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Δ9-Tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidancePublished by Elsevier ,1998
- CANNABINOID RECEPTORS AND THEIR ENDOGENOUS AGONISTSAnnual Review of Pharmacology and Toxicology, 1998
- Cannabinoid receptor agonists and antagonistsExpert Opinion on Therapeutic Patents, 1998
- Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brainEuropean Journal of Pharmacology, 1997
- An examination of the relationship between μ-opioid antinociceptive efficacy and G-protein coupling using pertussis and cholera toxinsLife Sciences, 1997
- Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and ratFEBS Letters, 1996
- Anandamides: tolerance and cross-tolerance toΔ9-tetrahydrocannabinolBrain Research, 1995
- Pharmacology of Cannabinoid ReceptorsAnnual Review of Pharmacology and Toxicology, 1995
- Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituentEuropean Journal of Pharmacology, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992